Research ArticleHuman Studies
Detecting Recurrent or Residual Lung Cancer with FDG-PET
Tomio Inoue, E. Edmund Kim, Ritsuko Komaki, Franklin C.L. Wong, Pedro Bassa, Wai-Hoi Wong, David J. Yang, Keigo Endo and Donald A. Podoloff
Journal of Nuclear Medicine May 1995, 36 (5) 788-793;
Tomio Inoue
E. Edmund Kim
Ritsuko Komaki
Franklin C.L. Wong
Pedro Bassa
Wai-Hoi Wong
David J. Yang
Keigo Endo
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Detecting Recurrent or Residual Lung Cancer with FDG-PET
Tomio Inoue, E. Edmund Kim, Ritsuko Komaki, Franklin C.L. Wong, Pedro Bassa, Wai-Hoi Wong, David J. Yang, Keigo Endo, Donald A. Podoloff
Journal of Nuclear Medicine May 1995, 36 (5) 788-793;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Use of Pre-treatment 18F-FAMT PET to Predict Patient Survival in Squamous Cell Carcinoma of the Esophagus Treated by Curative Surgery
- L-[3-18F]-{alpha}-Methyltyrosine Accumulation as a Definitive Chemoradiotherapy Response Predictor in Patients with Esophageal Cancer
- Value of 4-Dimensional 18F-FDG PET/CT in the Classification of Pulmonary Lesions
- Functional Imaging in Lung Cancer
- PET/CT Using 18F-FDG in Suspected Lung Cancer Recurrence: Diagnostic Value and Impact on Patient Management
- The CT Motion Quantitation of Lung Lesions and Its Impact on PET-Measured SUVs
- Clinical Applications of 18F-FDG in Oncology
- The Utility of 18F-FDG PET for Suspected Recurrent Non-Small Cell Lung Cancer After Potentially Curative Therapy: Impact on Management and Prognostic Stratification
- A Tabulated Summary of the FDG PET Literature
- The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
- Current role of positron emission tomography in thoracic oncology